Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
David Kokel
University of California, San Francisco, Department: Neurology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Teleos Therapeutics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
NA
Behavior-based chemical screening for GABAergic and startle modifying drugs
Neuroactive drugs are among our most powerful tools for understanding the nervous system and treating psychiatric disease. Behavior-modifying compounds have revolutionized neuroscience research and the treatment of anxiety disorders. Most neuroactive drugs were discovered via unexpected behavioral phenotypes. However, technologies for systematic behavior based screening for chemical modifiers of startle and anxiety- related behaviors have not been possible. Here, we combine high-throughput chemical screening strategies with complex behavioral phenotyping to identify novel startle modifying compounds. These efforts may improve our understanding of the brain and accelerate the pace of neuroactive drug discovery.
Filed on July 17, 2015.
Tell us what you know about David Kokel's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
David Kokel filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| David Kokel | University of California, San Francisco | Conflict of Interest | Teleos Therapeutics | $100,000 - $149,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.